Product Information
FENOFIBRATE 48 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0814 per EA under NDC 00378306577. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Dec 7, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the fenofibrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
48 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378306577
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA202856FDA Approved
12/7/2012
TE Code
AB
On Market Since
5/14/2013
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 48 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 92.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0814 per EA |
|---|---|
| All-time high | $1.0589 (Jan 15, 2014) |
| All-time low | $0.0814 (Aug 19, 2026) |
| 52-week high | $0.0976 |
| 52-week low | $0.0814 |
| Median price | $0.1859 |
| Average price | $0.3141 |
| Largest weekly change | -23.1% (Apr 17, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FENOFIBRATE 48 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 48 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.0814 per EA (NDC 00378306577), effective Aug 19, 2026.
How has the price of FENOFIBRATE 48 MG TABLET changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 48 MG TABLET has declined 92.3%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 48 MG TABLET?
Since Nov 28, 2013, the NADAC for FENOFIBRATE 48 MG TABLET has ranged from a low of $0.0814 (Aug 19, 2026) to a high of $1.0589 (Jan 15, 2014), with a median of $0.1859 per EA.
Are there cheaper alternatives to FENOFIBRATE 48 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FENOFIBRATE 48 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FENOFIBRATE 48 MG TABLET?
FENOFIBRATE 48 MG TABLET (NDC 00378306577) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.